Certara, Inc. (CERT)
NASDAQ: CERT · IEX Real-Time Price · USD
17.61
+0.31 (1.79%)
At close: May 2, 2024, 4:00 PM
17.33
-0.28 (-1.59%)
After-hours: May 2, 2024, 4:06 PM EDT
Certara Revenue
In the year 2023, Certara had annual revenue of $354.34M with 5.57% growth. Revenue in the quarter ending December 31, 2023 was $88.01M with 1.59% year-over-year growth.
Revenue (ttm)
$354.34M
Revenue Growth
+5.57%
P/S Ratio
7.94
Revenue / Employee
$254,735
Employees
1,391
Market Cap
2.82B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 354.34M | 18.69M | 5.57% |
Dec 31, 2022 | 335.64M | 49.54M | 17.32% |
Dec 31, 2021 | 286.10M | 42.57M | 17.48% |
Dec 31, 2020 | 243.53M | 35.02M | 16.79% |
Dec 31, 2019 | 208.51M | 44.79M | 27.36% |
Dec 31, 2018 | 163.72M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
QuidelOrtho | 3.00B |
GoodRx Holdings | 750.27M |
ACADIA Pharmaceuticals | 726.44M |
Azenta | 641.02M |
Arrowhead Pharmaceuticals | 181.74M |
Olink Holding AB (publ) | 169.60M |
Arcellx | 110.32M |
Merus | 43.95M |
CERT News
- 17 days ago - Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform - GlobeNewsWire
- 23 days ago - Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference - GlobeNewsWire
- 2 months ago - Certara Reports Fourth Quarter 2023 Financial Results - GlobeNewsWire
- 3 months ago - Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference - GlobeNewsWire
- 5 months ago - Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies - GlobeNewsWire
- 5 months ago - Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development - GlobeNewsWire
- 6 months ago - Certara Reports Third Quarter 2023 Financial Results - GlobeNewsWire
- 7 months ago - Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference - GlobeNewsWire